The U.S. Food and Drug Administration (FDA) has granted accelerated approval to atezolizumab (Tecentriq) for the treatment of people with locally advanced or metastatic urothelial carcinoma (mUC) who are not eligible for cisplatin...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pcVovI
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Cutaneous squamous cell carcinoma (cSCC) are amongst the most common cancers with metastatic potential. Specific clinical and pathological “...
-
PSA! Has a TON of Scholarship Opportunities Right Now. SPOILER: college is crazy-expensive. Sorry. Did we spoil it? There are... from #Ale...
-
A Vietnam War Timeline [Note: This timeline is an abbreviated version of the more detailed timeline posted on the Public Broadcasting System...
-
Fun math practice! Improve your skills with free problems in 'Solve two-step equations' and thousands of other practice lessons. f...
-
Greens Blue Flame supplies propane tank installation services and propane delivery in the Houston, TX area. We also offer bulk commercial de...
-
<div style=font-size:12px;text-align:center;>Vote for on globolister:<br /><a href=http:///details?site=2916&vote=1 targe...
-
IZE is a professional association dedicated to expanding the educational impact of zoos and aquariums worldwide, to enhance the understandin...
-
BibMe Free Bibliography & Citation Maker - MLA, APA, Chicago, Harvard from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inor...
-
Purpose. To assess the long-term clinical outcomes of conventional laser in situ keratomileusis (LASIK) for moderate to high myopia. Methods...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου